查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2151529

攜帶式血壓監測設備市場規模、佔有率和趨勢分析報告：按產品、最終用途、地區和細分市場分類（2026-2033 年）

Ambulatory Blood Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

全球攜帶式血壓監測設備市場預計到 2025 年將擴大到 38 億美元，2026 年至 2033 年的年複合成長率（CAGR）為 11.6%。

北美地區引領全球市場，預計2025年將佔據40.0%的最大市場。成長要素包括老年人口不斷成長、高血壓等慢性疾病盛行率上升以及血壓監測解決方案技術的持續進步。根據世界衛生組織（世衛組織）2025年更新的《高血壓概況介紹》，截至2024年，全球30至79歲成年人中約有14億人患有高血壓。高血壓仍然是全球過早死亡的主要原因之一，並顯著加重了包括心臟病、中風和腎臟病在內的心血管疾病負擔。

此外，世界衛生組織的報告顯示，近三分之二的高血壓患者居住在中低收入國家，這些國家的高血壓診斷和疾病管理仍然面臨嚴峻的醫療保健挑戰。這些因素促使人們迫切需要可靠的血壓篩檢和持續監測解決方案，從而導致全球對攜帶式血壓監測設備的需求不斷成長。

老年人口的成長是攜帶式血壓監測（ABPM）設備需求的主要促進因素。根據聯合國2025年發布的最新國際老年人日報告，預計到2025年，全球60歲以上人口將達到約12億，到2050年將增加至21億。由於老年人更容易患高血壓、心血管疾病和其他與老齡化相關的健康問題，老年人口的成長預計將持續推動對連續、準確、非侵入性血壓監測技術的需求。

此外，動態血壓監測（ABPM，即24小時血壓監測）設備的持續技術進步預計將在整個預測期內支撐市場成長。數位化、連網和行動血壓監測技術的日益普及正在提升患者的便利性、數據獲取能力和遠距醫療能力。例如，Omron Healthcare於2026年4月宣布支持“2026年5月測量月”，捐贈了3000台能夠檢測潛在心房顫動的先進血壓監測儀。這顯示業界對疾病早期檢測和遠距心血管監測的興趣日益濃厚。這些趨勢預計將加速先進血壓監測解決方案的普及，並進一步擴大全球攜帶式監測技術市場。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：攜帶式血壓計市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 攜帶式血壓計市場分析工具
  • 攜帶式血壓計市場：區域滲透率數據

第4章：攜帶式血壓計市場：產品具體估算與趨勢分析

  • 2023 年及 2030 年各產品市場佔有率
  • 全球攜帶式血壓計市場：按產品分類，展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 攜帶式血壓計
  • 設備和配件
    • 血壓袖帶
    • 其他

第5章：攜帶式血壓計市場：按最終用途分類的估算和趨勢分析

  • 按最終用途分類的市場佔有率，2023 年和 2030 年
  • 全球攜帶式血壓計市場：依最終用途分類，展望。
  • 市場規模、預測與趨勢分析，2021-2033年
    • 醫院
    • 門診手術中心及診所
    • 居家照護

第6章：攜帶式血壓計市場：區域估算與趨勢分析

  • 2023年及2030年區域市佔率分析
  • 區域市場概覽
  • 全球市場概述（按地區分類）
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司和競爭對手的分類
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Key company market share analysis, 2023
    • Omron Healthcare Welch Allyn, Inc.
    • A&D Medical Inc.
    • Microlife Corporation
    • Daray Medical
    • Withings
    • Briggs Healthcare
    • GE Healthcare
    • Rossmax International Ltd.
    • GF Health Products Inc
    • Spacelabs Healthcare Inc.
    • Philips Healthcare
    • Biobeat
    • Spacelabs Healthcare Inc
    • Bosch & Sohn GmbH & Co. KG
    • GE Company,
    • Schiller AG
    • DAIFUKU CO. LTD
Product Code: GVR-4-68040-206-0

The global ambulatory blood pressure monitoring devices market size was valued at USD 1.6 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 3.8 billion by 2033, at a CAGR of 11.6% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 40.0% in 2025. The market is primarily driven by the growing geriatric population, increasing prevalence of chronic diseases such as hypertension, and ongoing technological advancements in blood pressure monitoring solutions. According to the World Health Organization (WHO) Hypertension Fact Sheet updated in 2025, an estimated 1.4 billion adults aged 30-79 years worldwide were living with hypertension in 2024. Hypertension remains one of the leading causes of premature mortality globally and contributes significantly to the burden of cardiovascular diseases, including heart attack, stroke, and kidney disorders.

Furthermore, WHO reports that nearly two-thirds of individuals with hypertension reside in low- and middle-income countries, where diagnosis and disease management remain major healthcare challenges. These factors are increasing the need for reliable blood pressure screening and continuous monitoring solutions, thereby driving demand for ambulatory blood pressure monitoring devices worldwide.

The growing geriatric population is a key factor driving demand for ambulatory blood pressure monitoring (ABPM) devices. According to the United Nations International Day of Older Persons update published in 2025, the global population aged 60 years and above reached approximately 1.2 billion in 2025 and is projected to increase to 2.1 billion by 2050. As older adults are more susceptible to hypertension, cardiovascular diseases, and other age-related health conditions, the expanding elderly population is expected to drive sustained demand for continuous, accurate, and non-invasive blood pressure monitoring technologies.

Furthermore, ongoing technological advancements in ABPM devices are expected to support market growth throughout the forecast period. The increasing adoption of digital, connected, and mobile-enabled blood pressure monitoring technologies is enhancing patient convenience, data accessibility, and remote care capabilities. For instance, in April 2026, OMRON Healthcare announced its support for May Measurement Month 2026 through the donation of 3,000 advanced blood pressure monitors capable of detecting probable atrial fibrillation, highlighting the industry's growing focus on early disease detection and remote cardiovascular monitoring. Such developments are expected to accelerate the adoption of advanced blood pressure monitoring solutions and strengthen the broader market for ambulatory monitoring technologies worldwide.

Global Ambulatory Blood Pressure Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ambulatory blood pressure monitoring devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD B illion, 2021 - 2033)

Ambulatory Blood Pressure Monitors

Instrument & Accessories

    • Blood Pressure Cuffs
    • Others Type
  • End Use Outlook (Revenue, USD B illion, 2021 - 2033)

Hospitals

Ambulatory Surgical Centers & Clinics

Homecare

  • Regional Outlook (Revenue, USD B illion , 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Asia Pacific
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Blood Pressure Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing prevalence of chronic diseases
  • 3.3. Ambulatory Blood Pressure Monitoring Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Ambulatory Blood Pressure Monitoring Devices Market: Prevalence Data, By Region
    • 3.4.1. North America
      • 3.4.1.1. U.S.
      • 3.4.1.2. Canada
      • 3.4.1.3. Mexico
    • 3.4.2. Europe
      • 3.4.2.1. UK
      • 3.4.2.2. Germany
      • 3.4.2.3. France
      • 3.4.2.4. Italy
      • 3.4.2.5. Spain
      • 3.4.2.6. Denmark
      • 3.4.2.7. Sweden
      • 3.4.2.8. Norway
    • 3.4.3. Asia Pacific
      • 3.4.3.1. Japan
      • 3.4.3.2. China
      • 3.4.3.3. India
      • 3.4.3.4. South Korea
      • 3.4.3.5. Australia
      • 3.4.3.6. Thailand
    • 3.4.4. Latin America
      • 3.4.4.1. Brazil
      • 3.4.4.2. Argentina
    • 3.4.5. Middle East and Africa (MEA)
      • 3.4.5.1. South Africa
      • 3.4.5.2. Saudi Arabia
      • 3.4.5.3. UAE
      • 3.4.5.4. Kuwait

Chapter 4. Ambulatory Blood Pressure Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global ambulatory blood pressure monitoring devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Ambulatory blood pressure monitors
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Instrument & accessories
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.2. Blood Pressure Cuffs
      • 4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.3. Others
      • 4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Ambulatory Blood Pressure Monitoring Devices Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global ambulatory blood pressure monitoring devices Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
    • 5.4.2. Ambulatory Surgical Centers & Clinics
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Homecare
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Ambulatory Blood Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis by Product & End-use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Omron Healthcare Welch Allyn, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. A&D Medical Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Microlife Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Daray Medical
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Withings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Briggs Healthcare
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. GE Healthcare
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Rossmax International Ltd.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. GF Health Products Inc
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Spacelabs Healthcare Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Philips Healthcare
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Biobeat
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Spacelabs Healthcare Inc
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Bosch & Sohn GmbH & Co. KG
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. GE Company,
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. Schiller AG
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. DAIFUKU CO. LTD
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiative

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 3. North America ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 4. North America ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 5. U.S. ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 6. U.S. ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 7. Canada ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 8. Canada ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 9. Mexico ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 10. Mexico ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 11. Europe ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 12. Europe ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 13. Europe ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 14. Germany ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 15. Germany ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 16. UK ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 17. UK ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 18. France ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 19. France ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 20. Italy ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 21. Italy ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 22. Spain ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 23. Spain ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 24. Denmark ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 25. Denmark ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 26. Sweden ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 27. Sweden ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 28. Norway ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 29. Norway ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 30. Asia Pacific ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 31. Asia Pacific ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 32. Asia Pacific ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 33. China ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 34. China ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 35. Japan ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 36. Japan ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 37. India ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 38. India ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 39. South Korea ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 40. South Korea ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 41. Australia ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 42. Australia ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 43. Thailand ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 44. Thailand ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 45. Latin America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 46. Latin America ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 47. Latin America ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 48. Brazil ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 49. Brazil ambulatory blood pressure monitoring devices market, by end-use (USD Million) 2018-20
  • Table 50. Argentina ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 51. Argentina ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 52. MEA ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 53. MEA ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 54. MEA ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 55. South Africa ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 56. South Africa ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 57. Saudi Arabia ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 58. Saudi Arabia ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 59. UAE ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 60. UAE ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 61. Kuwait ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 62. Kuwait ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Ambulatory blood pressure monitoring devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Market dynamics
  • Fig. 11 Prevalence of rheumatoid arthritis in 2022, by WHO regions
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Ambulatory blood pressure monitoring devices market: Products outlook and key takeaways
  • Fig. 15 Ambulatory blood pressure monitoring devices market: Product movement analysis
  • Fig. 16 Ambulatory blood pressure monitors market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 17 Instrument & accessories market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 18 Blood pressure cuffs market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2021-2033, USD Million
  • Fig. 20 Ambulatory blood pressure monitoring devices market: End-use outlook and key takeaways
  • Fig. 21 Ambulatory blood pressure monitoring devices market: End-use movement analysis
  • Fig. 22 Hospitals market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 23 Ambulatory Surgical Centers & Clinics market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 24 Home-care market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 25 Provincial marketplace: Key takeaways (1/2)
  • Fig. 26 Provincial marketplace: Key takeaways (2/2)
  • Fig. 27 North America ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 28 Key country dynamics
  • Fig. 29 U.S. ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 30 Key country dynamics
  • Fig. 31 Canada ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 32 Europe ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 33 Key country dynamics
  • Fig. 34 UK ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 35 Key country dynamics
  • Fig. 36 Germany ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 37 Key country dynamics
  • Fig. 38 France ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 39 Key country dynamics
  • Fig. 40 Spain ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 41 Key country dynamics
  • Fig. 42 Italy ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 43 Key country dynamics
  • Fig. 44 Denmark ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 45 Key country dynamics
  • Fig. 46 Sweden ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 47 Key country dynamics
  • Fig. 48 Norway ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 49 Rest of Europe Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 50 Asia Pacific ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 51 Key country dynamics
  • Fig. 52 Reimbursement scenario
  • Fig. 53 Japan ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 54 Key country dynamics
  • Fig. 55 Regulatory framework
  • Fig. 56 Reimbursement scenario
  • Fig. 57 China ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 58 Key country dynamics
  • Fig. 59 Reimbursement scenario
  • Fig. 60 India ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 -2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 67 Key country dynamics
  • Fig. 68 Malaysia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 69 Key country dynamics
  • Fig. 70 Vietnam ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 71 Key country dynamics
  • Fig. 72 Philippines ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 73 Rest of Asia Pacific Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 74 Latin America ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 75 Key country dynamics
  • Fig. 76 Brazil regulation details
  • Fig. 77 Reimbursement scenario
  • Fig. 78 Brazil ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina pharmaceuticals registration details
  • Fig. 81 Argentina ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 82 Key country dynamics
  • Fig. 83 Regulatory framework
  • Fig. 84 Reimbursement scenario
  • Fig. 85 Mexico ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 86 Rest of Latin America Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 87 MEA Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 96 Key country dynamics
  • Fig. 97 Turkey ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 98 Rest of MEA ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 99 Company market share analysis, 2023
  • Fig. 100 Strategic framework